Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- BUSINESS NEWS IN BRIEF
September 19, 2005
- R&D NEWS IN BRIEF -2-
September 19, 2005
- SEMINAR
September 19, 2005
- Chuikyo to Conduct Survey on Med. Institutions' Costs and IT
September 19, 2005
- Goodrug to Begin Internet Sale of Generics on Oct. 1
September 19, 2005
- Incidence of Abnormality Rose in All Age Brackets in 2004: Health Examinations
September 19, 2005
- Kyorin to Back Up Toyo Pharmar in Earnest
September 19, 2005
- Kenporen Calls For Reductions in Medical Fees
September 19, 2005
- SSP to Raise Its Corporate Value
September 19, 2005
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
September 19, 2005
- Korosho Considering Sharp Increases in Initial, Follow-up Consultation Fees
September 19, 2005
- SURVEY 2 articles
September 19, 2005
- ABMJ Proposes Fund for Development of New Influenza Vaccines
September 19, 2005
- TOPICS 2 articles
September 19, 2005
- Association Calls on Gov't to Support Vaccine Business
September 19, 2005
- Orders for Flu Vaccine on aPar with Last Year's: Korosho
September 19, 2005
- REGULATORY NEWS IN BRIEF
September 19, 2005
- Information on Chugai's Clinical Trials Posted on JAPIC's Website
September 19, 2005
- Norvasc Reduces Risk of Death and Stroke: Pfizer
September 19, 2005
- Some Niche Drugs Hold Blockbuster Potential: Dr Aoki of JPMA
September 19, 2005
ページ
Japan’s pharmaceutical policy appears to be entering a new phase. The government’s newly approved honebuto policy and growth strategy both…
A few weeks ago, I had coffee with a very talented executive. Let’s call him Kenji. He has a great job, a big salary, and a solid team. But he was unhappy. He felt bored and wanted a new challenge.…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…